Title of article
Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation Original Research Article
Author/Authors
Hui-Ling Chen، نويسنده , , Chun-Yi Chang، نويسنده , , Hsun-Tzu Lee، نويسنده , , Hua-Hsuan Lin، نويسنده , , Pei-Jung Lu، نويسنده , , Chia-Ning Yang، نويسنده , , Chung-Wai Shiau، نويسنده , , Arthur Y. Shaw، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2009
Pages
9
From page
7239
To page
7247
Abstract
In the present study, we carried out Mannich-type reaction to synthesize clioquinol-derived 7-methyl-arylsulfonylpiperazine analogs with improved growth-inhibitory effects. 11 bearing 5-nitro group on the quinoline ring exhibited 26-fold more potent than that of clioquinol against HeLa cells with a GI50 value of 0.71 μM. In addition, 11 revealed synergistic effects on the growth inhibition of HeLa cells with GI50 values of 0.65, 0.25, and 0.06 μM in the presence of 1, 10, and 50 μM copper, respectively. Consistent to the clioquinol-mediated apoptosis, mechanistic study indicates that 9- and 11-induced growth inhibition is attributed to caspase-dependent pathway. Detection of reactive oxygen species in response to clioquinol, 9 and 11 confirmed that ROS was dramatically stimulated in the presence of copper and partially abolished upon treatment of 1 mM tempol. Further study indicated that 9- and 11-mediated induction of oxidative stress by ROS generation resulted in the activation MAPK pathway.
Keywords
Clioquinol , Metal-binding property , Mannich-type reaction , Reactive oxygen species (ROS) , MAPK pathway activation
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
2009
Journal title
Bioorganic and Medicinal Chemistry
Record number
1306442
Link To Document